{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:12:57Z","timestamp":1794366777196,"version":"4.9.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["G-13-0003064 and G-15-00093889"],"award-info":[{"award-number":["G-13-0003064 and G-15-00093889"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Evidence suggests that caffeine (CF) reduces cardiovascular disease (CVD) risk. However, the mechanism by which this occurs has not yet been uncovered. Here, we investigated the effect of CF on the expression of two bona fide regulators of circulating low-density lipoprotein cholesterol (LDLc) levels; the proprotein convertase subtilisin\/kexin type 9 (PCSK9) and the low-density lipoprotein receptor (LDLR). Following the observation that CF reduced circulating PCSK9 levels and increased hepatic LDLR expression, additional CF-derived analogs with increased potency for PCSK9 inhibition compared to CF itself were developed. The PCSK9-lowering effect of CF was subsequently confirmed in a cohort of healthy volunteers. Mechanistically, we demonstrate that CF increases hepatic endoplasmic reticulum (ER) Ca<jats:sup>2+<\/jats:sup> levels to block transcriptional\u00a0activation of the sterol regulatory element-binding protein 2 (SREBP2)\u00a0responsible for the regulation of PCSK9, thereby increasing the expression of the LDLR and clearance of LDLc. Our findings highlight ER Ca<jats:sup>2+<\/jats:sup> as a master regulator of cholesterol metabolism and identify a mechanism by which CF may protect against CVD.<\/jats:p>","DOI":"10.1038\/s41467-022-28240-9","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T11:04:57Z","timestamp":1644404697000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["Caffeine blocks SREBP2-induced hepatic PCSK9 expression to enhance LDLR-mediated cholesterol clearance"],"prefix":"10.1038","volume":"13","author":[{"given":"Paul F.","family":"Lebeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hyun","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khrystyna","family":"Platko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6258-779X","authenticated-orcid":false,"given":"Paul","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Sguazzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa E.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6795-4760","authenticated-orcid":false,"given":"Guillaume","family":"Par\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5425-8275","authenticated-orcid":false,"given":"Gregory R.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke J.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suleiman A.","family":"Igdoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0312-3746","authenticated-orcid":false,"given":"Mark A.","family":"Tarnopolsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. R.","family":"Wayne Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil G.","family":"Seidah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2947-8580","authenticated-orcid":false,"given":"Jakob","family":"Magolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0127-0865","authenticated-orcid":false,"given":"Richard C.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"key":"28240_CR1","doi-asserted-by":"publisher","first-page":"12027","DOI":"10.1073\/pnas.1534923100","volume":"100","author":"JD Horton","year":"2003","unstructured":"Horton, J. D. et al. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl Acad. Sci. USA 100, 12027\u201312032 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28240_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/ng1161","volume":"34","author":"M Abifadel","year":"2003","unstructured":"Abifadel, M. et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat. Genet. 34, 154\u2013156 (2003).","journal-title":"Nat. Genet."},{"key":"28240_CR3","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1073\/pnas.0335507100","volume":"100","author":"NG Seidah","year":"2003","unstructured":"Seidah, N. G. et al. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. Proc. Natl Acad. Sci. USA 100, 928\u2013933 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28240_CR4","doi-asserted-by":"publisher","first-page":"48865","DOI":"10.1074\/jbc.M409699200","volume":"279","author":"S Benjannet","year":"2004","unstructured":"Benjannet, S. et al. NARC-1\/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol. J. Biol. Chem. 279, 48865\u201348875 (2004).","journal-title":"J. Biol. Chem."},{"key":"28240_CR5","doi-asserted-by":"publisher","first-page":"7100","DOI":"10.1073\/pnas.0402133101","volume":"101","author":"KN Maxwell","year":"2004","unstructured":"Maxwell, K. N. & Breslow, J. L. Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype. Proc. Natl Acad. Sci. USA 101, 7100\u20137105 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28240_CR6","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","volume":"376","author":"MS Sabatine","year":"2017","unstructured":"Sabatine, M. S. et al. Investigators, evolocumab and clinical outcomes in patients with cardiovascular disease. N. Engl. J. Med. 376, 1713\u20131722 (2017).","journal-title":"N. Engl. J. Med."},{"key":"28240_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jacl.2019.05.005","volume":"4","author":"JG Robinson","year":"2019","unstructured":"Robinson, J. G. et al. Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit. A consensus statement from the National Lipid Association. J. Clin. Lipido. 4, 525\u2013537 (2019).","journal-title":"J. Clin. Lipido."},{"key":"28240_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.yrtph.2017.07.025","volume":"89","author":"D Turnbull","year":"2017","unstructured":"Turnbull, D., Rodricks, J. V., Mariano, G. F. & Chowdhury, F. Caffeine and cardiovascular health. Regul. Toxicol. Pharm. 89, 165\u2013185 (2017).","journal-title":"Regul. Toxicol. Pharm."},{"key":"28240_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/CIRCULATIONAHA.113.005925","volume":"129","author":"M Ding","year":"2014","unstructured":"Ding, M., Bhupathiraju, S. N., Satija, A., van Dam, R. M. & Hu, F. B. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation 129, 643\u2013659 (2014).","journal-title":"Circulation"},{"key":"28240_CR10","first-page":"1","volume":"49","author":"R Zucchi","year":"1997","unstructured":"Zucchi, R. & Ronca-Testoni, S. The sarcoplasmic reticulum Ca2+ channel\/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Pharm. Rev. 49, 1\u201351 (1997).","journal-title":"Pharm. Rev."},{"key":"28240_CR11","first-page":"834060","volume":"2010","author":"D Echeverri","year":"2010","unstructured":"Echeverri, D., Montes, F. R., Cabrera, M., Galan, A. & Prieto, A. Caffeine\u2019s vascular mechanisms of action. Int. J. Vasc. Med. 2010, 834060 (2010).","journal-title":"Int. J. Vasc. Med."},{"key":"28240_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pathophys.2008.02.002","volume":"15","author":"M Khazaei","year":"2008","unstructured":"Khazaei, M., Moien-Afshari, F. & Laher, I. Vascular endothelial function in health and diseases. Pathophysiology 15, 49\u201367 (2008).","journal-title":"Pathophysiology"},{"key":"28240_CR13","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1074\/jbc.M116.744235","volume":"292","author":"P Lebeau","year":"2017","unstructured":"Lebeau, P. et al. Endoplasmic reticulum stress and Ca2+ depletion differentially modulate the sterol regulatory protein PCSK9 to control lipid metabolism. J. Biol. Chem. 292, 1510\u20131523 (2017).","journal-title":"J. Biol. Chem."},{"key":"28240_CR14","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1172\/JCI11596","volume":"107","author":"GH Werstuck","year":"2001","unstructured":"Werstuck, G. H. et al. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J. Clin. Invest. 107, 1263\u20131273 (2001).","journal-title":"J. Clin. Invest."},{"key":"28240_CR15","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/j.biocel.2007.05.002","volume":"39","author":"SM Colgan","year":"2007","unstructured":"Colgan, S. M., Tang, D., Werstuck, G. H. & Austin, R. C. Endoplasmic reticulum stress causes the activation of sterol regulatory element binding protein-2. Int. J. Biochem. Cell Biol. 39, 1843\u20131851 (2007).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"28240_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.5483\/BMBRep.2013.46.4.153","volume":"46","author":"HY Quan","year":"2013","unstructured":"Quan, H. Y., Kim, D. Y. & Chung, S. H. Caffeine attenuates lipid accumulation via activation of AMP-activated protein kinase signaling pathway in HepG2 cells. BMB Rep. 46, 207\u2013212 (2013).","journal-title":"BMB Rep."},{"key":"28240_CR17","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1194\/jlr.M003566","volume":"51","author":"B Dong","year":"2010","unstructured":"Dong, B. et al. Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters. J. Lipid Res. 51, 1486\u20131495 (2010).","journal-title":"J. Lipid Res."},{"key":"28240_CR18","doi-asserted-by":"crossref","unstructured":"Tsuda, S. et al. Caffeine and contraction synergistically stimulate 5\u2019-AMP-activated protein kinase and insulin-independent glucose transport in rat skeletal muscle. Physiol. Rep. 3, e12592 (2015).","DOI":"10.14814\/phy2.12592"},{"key":"28240_CR19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","volume":"13","author":"Y Li","year":"2011","unstructured":"Li, Y. et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 13, 376\u2013388 (2011).","journal-title":"Cell Metab."},{"key":"28240_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1074\/jbc.M109.056762","volume":"285","author":"N Dzamko","year":"2010","unstructured":"Dzamko, N. et al. AMPK beta1 deletion reduces appetite, preventing obesity and hepatic insulin resistance. J. Biol. Chem. 285, 115\u2013122 (2010).","journal-title":"J. Biol. Chem."},{"key":"28240_CR21","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.1074\/jbc.M115.705012","volume":"291","author":"S Kang","year":"2016","unstructured":"Kang, S. et al. Small molecular allosteric activator of the sarco\/endoplasmic reticulum Ca2+-ATPase (SERCA) attenuates diabetes and metabolic disorders. J. Biol. Chem. 291, 5185\u20135198 (2016).","journal-title":"J. Biol. Chem."},{"key":"28240_CR22","doi-asserted-by":"publisher","first-page":"17404","DOI":"10.1073\/pnas.0408030101","volume":"101","author":"AE Palmer","year":"2004","unstructured":"Palmer, A. E., Jin, C., Reed, J. C. & Tsien, R. Y. Bcl-2-mediated alterations in endoplasmic reticulum Ca2+ analyzed with an improved genetically encoded fluorescent sensor. Proc. Natl Acad. Sci. USA 101, 17404\u201317409 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28240_CR23","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.bbamcr.2016.11.026","volume":"1864","author":"BP Diercks","year":"2017","unstructured":"Diercks, B. P., Fliegert, R. & Guse, A. H. Mag-Fluo4 in T cells: imaging of intra-organelle free Ca(2+) concentrations. Biochim. Biophys. Acta Mol. Cell Res. 1864, 977\u2013986 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"28240_CR24","doi-asserted-by":"publisher","first-page":"100779","DOI":"10.1016\/j.jbc.2021.100779","volume":"296","author":"PF Lebeau","year":"2021","unstructured":"Lebeau, P. F., Platko, K., Byun, J. H. & Austin, R. C. Calcium as a reliable marker for the quantitative assessment of endoplasmic reticulum stress in live cells. J. Biol. Chem. 296, 100779 (2021).","journal-title":"J. Biol. Chem."},{"key":"28240_CR25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1242\/jcs.02856","volume":"119","author":"DB Williams","year":"2006","unstructured":"Williams, D. B. Beyond lectins: the calnexin\/calreticulin chaperone system of the endoplasmic reticulum. J. Cell Sci. 119, 615\u2013623 (2006).","journal-title":"J. Cell Sci."},{"key":"28240_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nm.3440","volume":"20","author":"W Chen","year":"2014","unstructured":"Chen, W. et al. The ryanodine receptor store-sensing gate controls Ca2+ waves and Ca2+-triggered arrhythmias. Nat. Med. 20, 184\u2013192 (2014).","journal-title":"Nat. Med."},{"key":"28240_CR27","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1096\/fj.02-0037rev","volume":"16","author":"MD Bootman","year":"2002","unstructured":"Bootman, M. D. et al. 2-aminoethoxydiphenyl borate (2-APB) is a reliable blocker of store-operated Ca2+ entry but an inconsistent inhibitor of InsP3-induced Ca2+ release. FASEB J. 16, 1145\u20131150 (2002).","journal-title":"FASEB J."},{"key":"28240_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05734-x","volume":"7","author":"WA Wang","year":"2017","unstructured":"Wang, W. A. et al. Loss of calreticulin uncovers a critical role for calcium in regulating cellular lipid homeostasis. Sci. Rep. 7, 5941 (2017).","journal-title":"Sci. Rep."},{"key":"28240_CR29","first-page":"F96","volume":"28","author":"H Coe","year":"2009","unstructured":"Coe, H. & Michalak, M. Calcium binding chaperones of the endoplasmic reticulum. Gen. Physiol. Biophys. 28, F96\u2013F103 (2009).","journal-title":"Gen. Physiol. Biophys."},{"key":"28240_CR30","doi-asserted-by":"publisher","first-page":"30873","DOI":"10.1074\/jbc.272.49.30873","volume":"272","author":"JP Lievremont","year":"1997","unstructured":"Lievremont, J. P., Rizzuto, R., Hendershot, L. & Meldolesi, J. BiP, a major chaperone protein of the endoplasmic reticulum lumen, plays a direct and important role in the storage of the rapidly exchanging pool of Ca2+. J. Biol. Chem. 272, 30873\u201330879 (1997).","journal-title":"J. Biol. Chem."},{"key":"28240_CR31","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/353726a0","volume":"353","author":"GC Flynn","year":"1991","unstructured":"Flynn, G. C., Pohl, J., Flocco, M. T. & Rothman, J. E. Peptide-binding specificity of the molecular chaperone BiP. Nature 353, 726\u2013730 (1991).","journal-title":"Nature"},{"key":"28240_CR32","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/0092-8674(93)90492-9","volume":"75","author":"S Blond-Elguindi","year":"1993","unstructured":"Blond-Elguindi, S. et al. Affinity panning of a library of peptides displayed on bacteriophages reveals the binding specificity of BiP. Cell 75, 717\u2013728 (1993).","journal-title":"Cell"},{"key":"28240_CR33","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1016\/j.str.2015.10.012","volume":"23","author":"J Yang","year":"2015","unstructured":"Yang, J., Nune, M., Zong, Y., Zhou, L. & Liu, Q. Close and allosteric opening of the polypeptide-binding site in a human Hsp70 chaperone BiP. Structure 23, 2191\u20132203 (2015).","journal-title":"Structure"},{"key":"28240_CR34","first-page":"H1679","volume":"269","author":"Y Hatano","year":"1995","unstructured":"Hatano, Y., Mizumoto, K., Yoshiyama, T., Yamamoto, M. & Iranami, H. Endothelium-dependent and -independent vasodilation of isolated rat aorta induced by caffeine. Am. J. Physiol. 269, H1679\u2013H1684 (1995).","journal-title":"Am. J. Physiol."},{"key":"28240_CR35","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1161\/ATVBAHA.115.306032","volume":"35","author":"A Demers","year":"2015","unstructured":"Demers, A. et al. PCSK9 induces CD36 degradation and affects long-chain fatty acid uptake and triglyceride metabolism in adipocytes and in mouse liver. Arterioscler. Thromb. Vasc. Biol. 35, 2517\u20132525 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"28240_CR36","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1194\/jlr.M051326","volume":"55","author":"S Kuhnast","year":"2014","unstructured":"Kuhnast, S. et al. Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin. J. Lipid Res. 55, 2103\u20132112 (2014).","journal-title":"J. Lipid Res."},{"key":"28240_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1124\/pr.116.012989","volume":"69","author":"NG Seidah","year":"2017","unstructured":"Seidah, N. G., Abifadel, M., Prost, S., Boileau, C. & Prat, A. The proprotein convertases in hypercholesterolemia and cardiovascular diseases: emphasis on proprotein convertase subtilisin\/kexin 9. Pharm. Rev. 69, 33\u201352 (2017).","journal-title":"Pharm. Rev."},{"key":"28240_CR38","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.1021\/acs.jmedchem.9b00402","volume":"62","author":"C Lammi","year":"2019","unstructured":"Lammi, C. et al. Computationally driven structure optimization, synthesis, and biological evaluation of imidazole-based proprotein convertase subtilisin\/kexin 9 (PCSK9) inhibitors. J. Med. Chem. 62, 6163\u20136174 (2019).","journal-title":"J. Med. Chem."},{"key":"28240_CR39","doi-asserted-by":"publisher","first-page":"5704","DOI":"10.1021\/acs.jmedchem.8b00650","volume":"61","author":"AT Londregan","year":"2018","unstructured":"Londregan, A. T. et al. Small molecule proprotein convertase subtilisin\/kexin type 9 (PCSK9) inhibitors: hit to lead optimization of systemic agents. J. Med. Chem. 61, 5704\u20135718 (2018).","journal-title":"J. Med. Chem."},{"key":"28240_CR40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1136\/gutjnl-2015-309363","volume":"66","author":"W Huang","year":"2017","unstructured":"Huang, W. et al. Caffeine protects against experimental acute pancreatitis by inhibition of inositol 1,4,5-trisphosphate receptor-mediated Ca2+ release. Gut 66, 301\u2013313 (2017).","journal-title":"Gut"},{"key":"28240_CR41","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1158\/0008-5472.CAN-09-2886","volume":"70","author":"SS Kang","year":"2010","unstructured":"Kang, S. S. et al. Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival. Cancer Res. 70, 1173\u20131183 (2010).","journal-title":"Cancer Res."},{"key":"28240_CR42","doi-asserted-by":"publisher","first-page":"34086","DOI":"10.1074\/jbc.M607788200","volume":"45","author":"N Pierobon","year":"2006","unstructured":"Pierobon, N., Renard-Rooney, D., Gaspers, L. & Thomas, A. Ryanodine receptors in liver. J. Biol. Chem. 45, 34086\u201334095 (2006).","journal-title":"J. Biol. Chem."},{"key":"28240_CR43","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1085\/jgp.104.2.395","volume":"104","author":"A Guerrero","year":"1994","unstructured":"Guerrero, A., Singer, J. J. & Fay, F. S. Simultaneous measurement of Ca2+ release and influx into smooth muscle cells in response to caffeine. A novel approach for calculating the fraction of current carried by calcium. J. Gen. Physiol. 104, 395\u2013422 (1994).","journal-title":"J. Gen. Physiol."},{"key":"28240_CR44","doi-asserted-by":"crossref","unstructured":"Missiaen, L. et al. Inhibition of inositol trisphosphate-induced calcium release by cyclic ADP-ribose in A7r5 smooth-muscle cells and in 16HBE14o- bronchial mucosal cells. Biochem. J. 329, 489\u2013495 (1998).","DOI":"10.1042\/bj3290489"},{"key":"28240_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neulet.2014.03.053","volume":"569","author":"T Hosoi","year":"2014","unstructured":"Hosoi, T., Toyoda, K., Nakatsu, K. & Ozawa, K. Caffeine attenuated ER stress-induced leptin resistance in neurons. Neurosci. Lett. 569, 23\u201326 (2014).","journal-title":"Neurosci. Lett."},{"key":"28240_CR46","doi-asserted-by":"publisher","first-page":"L586","DOI":"10.1152\/ajplung.00405.2016","volume":"312","author":"RJ Teng","year":"2017","unstructured":"Teng, R. J. et al. Attenuation of endoplasmic reticulum stress by caffeine ameliorates hyperoxia-induced lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 312, L586\u2013L598 (2017).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"28240_CR47","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.bbrc.2015.02.004","volume":"460","author":"J Krebs","year":"2015","unstructured":"Krebs, J., Agellon, L. B. & Michalak, M. Ca(2+) homeostasis and endoplasmic reticulum (ER) stress: an integrated view of calcium signaling. Biochem. Biophys. Res. Commun. 460, 114\u2013121 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"28240_CR48","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1089\/ars.2006.8.1391","volume":"8","author":"A Gorlach","year":"2006","unstructured":"Gorlach, A., Klappa, P. & Kietzmann, T. The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid. Redox Signal 8, 1391\u20131418 (2006).","journal-title":"Antioxid. Redox Signal"},{"key":"28240_CR49","doi-asserted-by":"publisher","first-page":"422","DOI":"10.2337\/db07-1762","volume":"58","author":"DS Luciani","year":"2009","unstructured":"Luciani, D. S. et al. Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. Diabetes 58, 422\u2013432 (2009).","journal-title":"Diabetes"},{"key":"28240_CR50","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.devcel.2008.11.013","volume":"15","author":"S Basseri","year":"2008","unstructured":"Basseri, S. & Austin, R. C. ER stress and lipogenesis: a slippery slope toward hepatic steatosis. Dev. Cell 15, 795\u2013796 (2008).","journal-title":"Dev. Cell"},{"key":"28240_CR51","doi-asserted-by":"publisher","first-page":"16314","DOI":"10.1073\/pnas.0808517105","volume":"105","author":"E Bobrovnikova-Marjon","year":"2008","unstructured":"Bobrovnikova-Marjon, E. et al. PERK-dependent regulation of lipogenesis during mouse mammary gland development and adipocyte differentiation. Proc. Natl Acad. Sci. USA 105, 16314\u201316319 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28240_CR52","doi-asserted-by":"publisher","first-page":"18044","DOI":"10.1074\/jbc.270.30.18044","volume":"270","author":"X Wang","year":"1995","unstructured":"Wang, X. et al. Purification of an interleukin-1 beta converting enzyme-related cysteine protease that cleaves sterol regulatory element-binding proteins between the leucine zipper and transmembrane domains. J. Biol. Chem. 270, 18044\u201318050 (1995).","journal-title":"J. Biol. Chem."},{"key":"28240_CR53","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1073\/pnas.93.11.5437","volume":"93","author":"JT Pai","year":"1996","unstructured":"Pai, J. T., Brown, M. S. & Goldstein, J. L. Purification and cDNA cloning of a second apoptosis-related cysteine protease that cleaves and activates sterol regulatory element binding proteins. Proc. Natl Acad. Sci. USA 93, 5437\u20135442 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28240_CR54","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1172\/JCI37007","volume":"119","author":"HL Kammoun","year":"2009","unstructured":"Kammoun, H. L. et al. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J. Clin. Invest. 119, 1201\u20131215 (2009).","journal-title":"J. Clin. Invest."},{"key":"28240_CR55","first-page":"493","volume":"11","author":"I Giunzioni","year":"2015","unstructured":"Giunzioni, I. & Tavori, H. New developments in atherosclerosis: clinical potential of PCSK9 inhibition. Vasc. Health Risk Manag. 11, 493\u2013501 (2015).","journal-title":"Vasc. Health Risk Manag."},{"key":"28240_CR56","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1194\/jlr.M071498","volume":"57","author":"KK Jensen","year":"2016","unstructured":"Jensen, K. K. et al. Dose-dependent effects of siRNA-mediated inhibition of SCAP on PCSK9, LDLR, and plasma lipids in mouse and rhesus monkey. J. Lipid Res. 57, 2150\u20132162 (2016).","journal-title":"J. Lipid Res."},{"key":"28240_CR57","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1194\/jlr.M028563","volume":"53","author":"Y Wang","year":"2012","unstructured":"Wang, Y., Huang, Y., Hobbs, H. H. & Cohen, J. C. Molecular characterization of proprotein convertase subtilisin\/kexin type 9-mediated degradation of the LDLR. J. Lipid Res. 53, 1932\u20131943 (2012).","journal-title":"J. Lipid Res."},{"key":"28240_CR58","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1476-511X-7-22","volume":"7","author":"J Mayne","year":"2008","unstructured":"Mayne, J. et al. Plasma PCSK9 levels are significantly modified by statins and fibrates in humans. Lipids Health Dis. 7, 22 (2008).","journal-title":"Lipids Health Dis."},{"key":"28240_CR59","first-page":"e201702","volume":"2017","author":"NG Seidah","year":"2017","unstructured":"Seidah, N. G. The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol. Glob. Cardiol. Sci. Pr. 2017, e201702 (2017).","journal-title":"Glob. Cardiol. Sci. Pr."},{"key":"28240_CR60","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1016\/j.tet.2012.03.050","volume":"68","author":"P Bandyopadhyay","year":"2012","unstructured":"Bandyopadhyay, P., Agrawal, S. K., Sathe, M., Sharma, P. & Kaushik, M. P. A facile and rapid one-step synthesis of 8-substituted xanthine derivatives via tandem ring closure at room temperature. Tet J. 68, 3822\u20133827 (2012).","journal-title":"Tet J."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28240-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28240-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28240-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T16:26:16Z","timestamp":1669307176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28240-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["28240"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-28240-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,9]]},"assertion":[{"value":"17 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: P.F.L., J.H.B, P.S., M.S., J.M., and R.C.A. have filed an institution-owned patent, entitled: \u201cCompounds for Reducing Cholesterol and Treating Liver and Kidney Disease\u201d (18-069_USProv) that relates to the development of caffeine and methylxanthine derivatives to lower cholesterol. R.C.A, J.M., G.P., and M.A.T. have an equity stake in Systemic Therapeutics.\u00a0G.P. has received honoraria from Amgen and Sanofi. G.R.S. is a co-founder and shareholder of Espervita Therapeutics, a company developing new medications for liver cancer. McMaster University has received funding from Espervita Therapeutics, Esperion Therapeutics, Poxel Pharmaceuticals and Novo Nordisk for research conducted in the laboratory of G.R.S. G.R.S. has received consulting\/speaking fees from Astra Zeneca, Eli Lilly, Esperion Therapeutics, Merck, Poxel Pharmaceuticals and Takeda. M.A.T. is the CEO of Exerkine Corporation and Stayabove Nutrition and is actively evaluating and marketing multi-nutrient supplements for the treatment of aging, obesity, muscular dystrophy and mitochondrial disease. No other authors declare any competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"770"}}